As technology advances, the resolution and accuracy of CMA are expected to improve further. Integrating CMA with other genomic technologies, such as whole exome sequencing and whole genome sequencing, could provide even more comprehensive insights into neonatal disorders. The continued research and development in this field promise to enhance our understanding and management of these conditions.
